NSite Medical Announces FDA Clearance for Groundbreaking AI-Based Scoliosis Scanning App

MENLO PARK, Calif., Dec. 6, 2023 /PRNewswire/ — NSite Medical, a leader in scoliosis care and treatment, is excited to announce the FDA clearance of its innovative AI-based Scoliosis Assessment Application. This technological breakthrough signifies a major advancement in scoliosis…

Click here to view original post